S Donohoe

489 total citations
19 papers, 353 citations indexed

About

S Donohoe is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, S Donohoe has authored 19 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 9 papers in Hematology and 4 papers in Genetics. Recurrent topics in S Donohoe's work include Systemic Lupus Erythematosus Research (10 papers), Platelet Disorders and Treatments (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). S Donohoe is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Platelet Disorders and Treatments (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). S Donohoe collaborates with scholars based in United Kingdom, United States and France. S Donohoe's co-authors include Ian Mackie, David Isenberg, A. J. Thody, Samuel J. Machin, C T Ravirajan, SJ Machin, John‏ Kingdom, Paul A. Lucas, Sam Shuster and MJ Adams and has published in prestigious journals such as British Journal of Haematology, Physiology & Behavior and Thrombosis and Haemostasis.

In The Last Decade

S Donohoe

19 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Donohoe United Kingdom 11 216 185 63 53 51 19 353
William Lloyd United States 6 159 0.7× 35 0.2× 128 2.0× 30 0.6× 73 1.4× 18 287
Françoise Rossi France 5 51 0.2× 171 0.9× 193 3.1× 40 0.8× 132 2.6× 9 402
Daria Sollazzo Italy 13 47 0.2× 178 1.0× 64 1.0× 109 2.1× 6 0.1× 25 407
Christine Lombard France 12 46 0.2× 31 0.2× 89 1.4× 19 0.4× 20 0.4× 33 412
Annalisa Andreoli France 12 60 0.3× 154 0.8× 36 0.6× 109 2.1× 7 0.1× 17 376
Sarah Fleischer Germany 11 172 0.8× 18 0.1× 237 3.8× 30 0.6× 68 1.3× 27 448
Kamel Hamzaoui Tunisia 14 202 0.9× 85 0.5× 110 1.7× 9 0.2× 5 0.1× 34 506
G.M. Steup-Beekman Netherlands 5 168 0.8× 33 0.2× 73 1.2× 4 0.1× 48 0.9× 8 218
Rita Prajapati United States 6 128 0.6× 39 0.2× 55 0.9× 40 0.8× 24 0.5× 7 325
Fulvio Parentin Italy 11 102 0.5× 120 0.6× 10 0.2× 15 0.3× 115 2.3× 29 447

Countries citing papers authored by S Donohoe

Since Specialization
Citations

This map shows the geographic impact of S Donohoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Donohoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Donohoe more than expected).

Fields of papers citing papers by S Donohoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Donohoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Donohoe. The network helps show where S Donohoe may publish in the future.

Co-authorship network of co-authors of S Donohoe

This figure shows the co-authorship network connecting the top 25 collaborators of S Donohoe. A scholar is included among the top collaborators of S Donohoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Donohoe. S Donohoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Alunno, Alessia, Francesco Carubbi, Javier Rodríguez‐Carrio, et al.. (2024). The management of cardiovascular risk in psoriatic disease: A bridge over troubled water. Seminars in Arthritis and Rheumatism. 65. 152389–152389. 4 indexed citations
2.
3.
Nicholls, P J, et al.. (2002). Antibodies to Factor XII Are Distinct from Antibodies to Prothrombin in Patients with the Anti-phospholipid Syndrome. Thrombosis and Haemostasis. 87(3). 426–430. 10 indexed citations
4.
Donohoe, S, et al.. (2002). Patients with Essential Thrombocythaemia have an Increased Prevalence of Antiphospholipid Antibodies which may be associated with Thrombosis. Thrombosis and Haemostasis. 87(5). 802–807. 36 indexed citations
5.
Adams, MJ, et al.. (2001). Anti‐tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome. British Journal of Haematology. 114(2). 375–379. 29 indexed citations
6.
Donohoe, S, et al.. (2001). Anti‐prothrombin antibodies: assay conditions and clinical associations in the anti‐phospholipid syndrome. British Journal of Haematology. 113(2). 544–549. 33 indexed citations
7.
Pittoni, Valerio, C T Ravirajan, S Donohoe, et al.. (2000). Human monoclonal anti-phospholipid antibodies selectively bind to membrane phospholipid andβ2-glycoprotein I (β2-GPI) on apoptotic cells. Clinical & Experimental Immunology. 119(3). 533–543. 28 indexed citations
8.
Donohoe, S, Michael Geary, John‏ Kingdom, et al.. (1999). Maternal cardiolipin, β2‐glycoprotein‐I and prothrombin antibody expression in high‐risk pregnancies with bilateral abnormal uterine artery Doppler waveforms. Ultrasound in Obstetrics and Gynecology. 13(5). 317–322. 2 indexed citations
9.
Donohoe, S, John‏ Kingdom, & Ian Mackie. (1999). Affinity purified human antiphospholipid antibodies bind normal term placenta. Lupus. 8(7). 525–531. 15 indexed citations
10.
Harrison, Claire, et al.. (1998). Evaluation of risk factors for thrombosis in patients with essential thrombocythaemia. UCL Discovery (University College London). 2 indexed citations
11.
İnanç, Murat, S Donohoe, C T Ravirajan, et al.. (1998). Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.. PubMed. 37(10). 1089–94. 38 indexed citations
12.
Atsumi, Tatsuya, Munther A. Khamashta, Olga Amengual, et al.. (1998). Binding of anticardiolipin antibodies to protein C via β2-glycoprotein I (β2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Clinical & Experimental Immunology. 112(2). 325–333. 44 indexed citations
13.
Cardigan, Rebecca, S Donohoe, G. Purdy, IJ Mackie, & S. J. Machin. (1998). The association of factor VIIa, factor XIIa and ??2-glycoprotein-1 with triglyceriderich lipoproteins in normolipidaemic subjects. Blood Coagulation & Fibrinolysis. 9(4). 323–332. 3 indexed citations
14.
Joseph, Joanne, S Donohoe, Paul Harrison, Ian Mackie, & S. J. Machin. (1998). Platelet activation and turnover in the primary antiphospholipid syndrome. Lupus. 7(5). 333–340. 23 indexed citations
15.
Donohoe, S, John Kingdom, Siobhan Quenby, et al.. (1998). Localization of βGPI and annexin V in villous placenta during normal and IUGR/APS pregnancies. Journal of the Society for Gynecologic Investigation. 5(1). 56A–56A. 1 indexed citations
16.
Lucas, Paul A., S Donohoe, & A. J. Thody. (1982). The role of estrogen and progesterone in the control of preputial gland sex attractant odors in the female rat. Physiology & Behavior. 28(4). 601–607. 29 indexed citations
17.
Thody, A. J., S Donohoe, & Sam Shuster. (1981). α-Melanocyte stimulating hormone and the release of sex attractant odors in the female rat. Peptides. 2(2). 125–129. 10 indexed citations
18.
Donohoe, S, A. J. Thody, & Sam Shuster. (1981). EFFECT OF α-MELANOCYTE-STIMULATING HORMONE AND OVARIAN STEROIDS ON PREPUTIAL GLAND FUNCTION IN THE FEMALE RAT. Journal of Endocrinology. 90(1). 53–58. 8 indexed citations
19.
Thody, A. J., S Donohoe, & Sam Shuster. (1979). THE PRODUCTION OF PREPUTIAL GLAND SEX ATTRACTANTS IN THE FEMALE RAT BY α-MSH.. European Journal of Endocrinology. 92(2_Supplb). S254–S260. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Lloyd Breakdown of academic impact, for papers by Françoise Rossi Breakdown of academic impact, for papers by Daria Sollazzo Breakdown of academic impact, for papers by Christine Lombard Breakdown of academic impact, for papers by Annalisa Andreoli Breakdown of academic impact, for papers by Sarah Fleischer Breakdown of academic impact, for papers by Kamel Hamzaoui Breakdown of academic impact, for papers by G.M. Steup-Beekman Breakdown of academic impact, for papers by Rita Prajapati Breakdown of academic impact, for papers by Fulvio Parentin
Rankless by CCL
2026